Table 2.
Daily dietary intakes of selected nutrients in pregnant Indigenous women from the Gomeroi gaaynggal cohort (n = 103).
| Meeting | EAR | Median | IQR | Meeting EAR or AI n (%) |
|---|---|---|---|---|
| Energy (kJ/day) | - | 8506 | 6918–11434 | - |
| Protein (g) | 47 (≤18 y) 49 |
92.0 | 69.6–122.4 | 95 (92.2) |
| Fibre (g) | 25 * (≤18 y) 28 * |
23.0 | 15.9–30.4 | 37 (35.9) |
| Thiamin (mg) | 1.2 | 1.6 | 1.1–2.0 | 73 (70.9) |
| Riboflavin (mg) | 1.2 | 2.2 | 1.7–3.0 | 95 (92.2) |
| Niacin equivalents 1 (mg) | 14 | 39.4 | 29.4–51.6 | 101 (98.1) |
| Vitamin C (mg) | 38 (≤18 y) 40 |
184.5 | 113.9–239.6 | 97 (94.2) |
| Dietary folate equivalents 2 (μg) | 520 | 563.9 | 416.4–672.3 | 59 (57.3) |
| Retinol equivalents 3 (μg) | 530 (≤18 y) 550 |
1057 | 680.1–1418.2 | 86 (83.5) |
| Potassium (mg) | 2800 * | 3399.5 | 2695.3–4307.8 | 72 (69.9) |
| Magnesium (mg) | 290 + | 358 | 285.9–422.6 | 75 (72.8) |
| Calcium (mg) | 1050 (≤18 y) 840 |
843.7 | 557.3–1101.7 | 52 (50.5) |
| Phosphorus (mg) | 1055 (≤18 y) 580 |
1447.6 | 1115.9–1903.8 | 98 (95.2) |
| Iron (mg) | 23 (≤18 y) 22 |
10.7 | 7.7–13 | 4 (3.88) |
| Zinc (mg) | 8.5 (≤18 y) 9.0 |
12.2 | 9.0–15.4 | 78 (75.7) |
| Exceeding | Upper Limit | Median | IQR | Exceeding Upper Limit n (%) |
| Sodium (mg) | 460–920 * | 1914.5 | 1434.2–2441.1 | 95 (92.2) 4 |
| %E Saturated fat | 10% 5 | 15 | 13–17 | 99 (96.1) |
EAR: Estimated Average Requirement. AI: Adequate Intake. IQR: Interquartile range. Star (*) denotes adequate intake. + Magnesium recommendations are for pregnant women aged 19–30 years. The recommendation for pregnant women aged 31–50 years is EAR: 300mg/day. 1 Niacin intakes and requirements are expressed as niacin equivalents: 1 mg niacin equivalent = 1 mg niacin/60 mg tryptophan. Niacin + Niacin derived from tryptophan. 2 1 µg dietary folate equivalent = 1 µg food folate = 0.5 µg folic acid on an empty stomach = 0.6 µg folic acid with meals or as fortified foods. 3 Retinol + (Beta-carotene/6) + (alpha-carotene/12) + (cryptoxanthin/12). 4 Comparison made relative to the upper end level of sodium AI. 5 For chronic disease risk reduction for general population.